TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Código da empresaTELA
Nome da EmpresaTELA Bio Inc
Data de listagemNov 08, 2019
CEOMr. Antony Koblish
Número de funcionários209
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 08
Endereço1 Great Valley Parkway, Suite 24
CidadeMALVERN
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal19355
Telefone14843202930
Sitehttps://www.telabio.com/
Código da empresaTELA
Data de listagemNov 08, 2019
CEOMr. Antony Koblish
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados